Clinical trial

Assess Efficacy and Safety of TachoComb H vs. Standard Surgical Treatment (i.e…

NCT00290836 · Nycomed, Industry · Completed

Key facts

NCT number NCT00290836
Title Assess Efficacy and Safety of TachoComb H vs. Standard Surgical Treatment (i.e. Suturing) in Patients Undergoing Prostatectomy (TC-017-AU)
Official title An Open, Randomised, Prospective, Single-centre Phase IV Trial to Assess Efficacy and Safety of TachoComb H Versus Standard Surgical Treatment (i.e. Suture) in Patients Undergoing Prostatectomy
Lead sponsor Nycomed, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Control of Local Bleeding in Patients Undergoing Prostatectomy.
Intervention type Drug
Interventions Human fibrinogen/thrombin and bovine aprotinin (TachoComb H)
Enrollment 120
Start date May 1, 2004
Completion Aug 1, 2007
First posted Feb 13, 2006
Last update posted May 7, 2012
Countries Denmark

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies